Others

Torrent Pharmaceuticals Ltd. - Submission / Intimation Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements), 2015, (Listing Regulations)

| Updated on May 20, 2019 Published on May 20, 2019

We would like to inform that the Board has at its meeting held today approved, inter-alia, the following:

(a) Audited Financial Results (both standalone and consolidated) of the Company along with audit reports for the quarter and year ended on 31st March, 2019. The said financial results are enclosed herewith.

We declare that the aforesaid Audit Reports are with unmodified opinion.

In terms of Regulation 47 of the Listing Regulations, the Company will publish an extract of Audited Consolidated Financial Results for the quarter and year ended on 31st March, 2019. Both Audited Standalone and Consolidated Financial Results will be available at Companys website www.torrentpharma.com.

A Press Release on Financial Results which is being submitted to the media is also enclosed herewith.

Pdf Link: Torrent Pharmaceuticals Ltd. - Submission / Intimation Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements), 2015, (Listing Regulations)

Source : BSE - www.bseindia.com

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on May 20, 2019
This article is closed for comments.
Please Email the Editor